Question · asked by 1 review

Angiotensin‐converting enzyme inhibitors vs ARB: Cardiovascular events

Population
people with primary hypertension
Intervention
Angiotensin‐converting enzyme inhibitors
Comparison
ARB
Outcome
Cardiovascular events

All angiotensin converting enzyme (ACE) inhibitors showed no clear difference in total cardiovascular events compared with all angiotensin receptor blockers (ARBs) (low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
All angiotensin converting enzyme (ACE) inhibitors vs all angiotensin receptor blockers (ARBs)
Total cardiovascular events · people with primary hypertension
All angiotensin converting enzyme (ACE) inhibitors showed no clear difference in total cardiovascular events compared with all angiotensin receptor blockers (ARBs) (low certainty).
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension (2014) · Cochrane Headline outcomes only
RR 1.07 [0.96, 1.19]3 studies · 5499 participantsLow

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
2014 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.